[Skip to Navigation]
Comment & Response
August 2017

Marketing Claims for Infant Formula Additives and Infant Formula

Author Affiliations
  • 1University of Hawai’i, Honolulu, Hawaii
JAMA Pediatr. 2017;171(8):811. doi:10.1001/jamapediatrics.2017.1592

To the Editor The authors of the JAMA Pediatrics Viewpoint “Marketing Claims for Infant Formula: The Need for Evidence” are concerned that the increased costs of formula with certain additives might reduce the reach of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) program.1 With WIC already serving more than half of all infants in the United States, it can be argued that the program already reaches too many families.2 The difference between numbers eligible and participating is not solely owing to inadequate funding because some who are eligible might choose not to participate. If by some standards there is a funding shortfall, increases in the cost to WIC of formula might explain only a small share of that shortfall.

×